[125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys

Experimental Neurology

Volumn 154, Issue 1, 1998, Pages 146-156

  Villares, Joao ^a   Faucheux, Baptiste ^a   Herrero, Maria T ^b   Obeso, Jose A ^c   Duyckaerts, Charles ^a   Hauw, Jean Jacques ^a   Agid, Yves ^a   Hirsch, Etienne C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF MURCIA   (Spain)

^c Quiron Clinic   (Spain)

Author keywords

Autoradiography; Dopaminergic neurons; Epidermal growth factor; Parkinson's disease; Receptor; Trophic factor

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; EPIDERMAL GROWTH FACTOR; IODINE 125; LEVODOPA; DIHYDROTETRABENAZINE; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR; RADIOACTIVE IODINE; TETRABENAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN TISSUE; MONKEY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN EXPRESSION; RECEPTOR BINDING; AGED; ANIMAL; BRAIN DISEASE; CHEMICALLY INDUCED DISORDER; FEMALE; IMMUNOHISTOCHEMISTRY; MACACA; MALE; METABOLISM;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; AGED; AGED, 80 AND OVER; ANIMALS; BASAL GANGLIA; BRAIN DISEASES; DOPAMINE AGENTS; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IODINE RADIOISOTOPES; MACACA FASCICULARIS; MALE; PARKINSON DISEASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SUPRANUCLEAR PALSY, PROGRESSIVE; TETRABENAZINE;

EID: 0032194825     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6933     Document Type: Article

References (61)

1. Abe K., Takayanagi M., Saito H. A comparison of neutrotrophic effects of epidermal growth factor and basic fibroblast growth factor in primary cultured neurons from various regions of fetal rat brain. Jpn. J. Pharmacol. 54:1990;45-51.
2. Abe K., Takayanagi M., Saito H. Basic fibroblast growth factor and epidermal growth factor promote survival of primary cultured cerebellar neurons from neonatal rats. Jpn. J. Pharmacol. 56:1991;113-116.
3. Agid Y., Javoy-Agid F., Ruberg M., Pillon B., Dubois B., Duyckaerts C., Hauw J.-J., Baron J. C., Scatton B. Progressive supranuclear palsy: Anatomoclinical and biochemical considerations. Parkinson's Disease. 1986;Raven Press, New York. p. 191-206.
4. Alexi T., Hefti F. Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture. Neuroscience. 55:1993;903-918.
5. Altar C. A., Boylan C. B., Jackson C., Hershenson S., Miller J., Weigand S. J., Lindsay R. M., Hyman C. Brain derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnoverin vivo. Proc. Natl. Acad. Sci. USA. 80:1992;11347-11351.
6. Anglade P., Blanchard V., Vozari-Raisman R., Faucheux B. A., Herrero M. T., Obeso J. A., Mouatt-Prigent A., Kastner A., Strada O., Javoy-Agid F., Agid Y., Hirsch E. C. Is dopaminergic cell death accompanied by concomitant nerve plasticity. Battistin L., Scarlato G., Caraceni T., Ruggieri S. Parkinson's Disease. 1996;195-208 Lippincott-Raven, Philadelphia.
7. Birecree E., Whetsell W. O. Jr., Stoscheck C., King L. E. Jr., Nanney L. B. Immunoreactive epidermal growth factor receptors in neuritic plaques from patients with Alzheimer's disease. J. Neuropathol. Exp. Neurol. 47:1988;549-560.
8. Birecree E., King L. E. Jr., Nanney L. B. Epidermal growth factor and its receptor in the developing human nervous system. Dev. Brain Res. 60:1991;145-154.
9. Birman P., Bai-Grenier F., Joubert (Bression) D. EGF binding site number of the rat anterior pituitary is increased by chronic administration with dopaminergic agonist, CV 205-502. C. R. Acad. Sci. III. 312:1991;241-245.
10. Callaway J., Kinyano R., Opole I., Kimani J., Loughlin S. E., Fallon J. H. Localization of transforming growth factor alpha precursor and epidermal growth factor in forebrain regions of the Vervet monkey (Cercopithecos aethiops. Soc. Neurosci. Abst. 17:1991;752.
11. Casper D., Mytilineou C., Blum M. EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture. J. Neurosci. Res. 30:1991;372-381.
12. Clark A. J. L., Ishii S., Richert N., Merlino G. T., Pastan I. Epidermal growth factor regulates the expression of its own receptor. Proc. Natl. Acad. Sci. USA. 82:1985;8374-8378.
13. Date I., Notter M. F. D., Felten S. Y., Felten D. L. MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF). Brain Res. 526:1990;156-160.
14. Engele J., Bohn M. C. The neurotrophic effects of fibroblast growth factors on dopaminergic neuronsin vitro. J. Neurosci. 11:1991;3070-3078.
15. Fallon J. H., Seroogy K. B., Loughlin S. E., Morrison R. S., Bradshaw R. A., Knauer D. J., Cunninghan D. D. Epidermal growth factor immunoreactive material in the central nervous system: Location and development. Science. 224:1984;1107-1109.
16. Fallon J. H., Annis C. M., Gentry L. E., Twardzik D. R., Loughlin S. E. Localization of cells containing transforming growth factor-alpha precursor immunoreactivity in the basal ganglia of the adult rat brain. Growth Factors. 2:1990;241-250.
17. Gash D. M., Bresjanac M., Junn F., Zang Z. Trophic mechanisms mediating functional recovery following intrastriatal implantation. Dunnett S. B., Bjorklung A. Functional Neural Transplantation. 1994;139-156 Raven, New York.
18. Gomez-Pinilla F., Knauer D. J., Nieto-Sampedro M. Epidermal growth factor receptor immunoreactivity in rat brain. Development and cellular localization. Brain Res. 438:1988;385-390.
19. Goodman R., Slater E., Herschman H. R. Epidermal growth factor induces tyrosine hydroxylase in a clonal pheochromocytoma cell line, PC-G2. J. Cell Biol. 84:1980;495-500.
20. Graybiel A. M., Ragsdale C. W. Jr. Histochemically distinct compartments in the striatum of human, monkey, and cat demonstrated by acetylcholinesterase staining. Proc. Natl. Acad. Sci. USA. 75:1978;5723-5726.
21. Hadjiconstantinou M., Fitkin J. G., Dalia A., Neff N. H. Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine-treated mouse. J. Neurochem. 57:1991;479-482.
22. Hanley M. R. Peptide regulatory factors in the nervous system. Lancet. 8651:1989;1373-1376.
23. Hauw J-J., Daniel S. E., Dickson D., Horoupian D. S., Jellinger K., Lantos P. L., Mckee A., Tabaton M., Litvan I. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 44:1994;2015-2019.
24. Herschman H. R. Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem. 60:1991;281-319.
25. Holtzman D. M., Mobley W. C. Neurotrophic factors and neurologic disease, in Neurology - From basics to bedside [Special Issue]. West J. Med. 161:1994;246-254.
26. Hyman C., Hofer M., Barde Y.-A., Juhasz M., Yancopoulos G. D., Squinto S. P., Lindsay R. M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 350:1991;230-232.
27. Kaser M. R., Lakshmanan J., Fisher D. A. Comparison between epidermal growth factor, transforming growth factor-alpha and EGF receptor levels in regions of adult rat brain. Mol. Brain Res. 16:1992;316-322.
28. Lazar L. M., Blum M. Regional distribution and developmental expression of epidermal growth factor and transforming growth factor alpha mRNA in mouse brain by a quantitative nuclease protection assay. J. Neurosci. 12:1992;1688-1697.
29. Lehéricy S., Brandel J. P., Hirsch E. C., Anglade P., Villares J., Scherman D., Duyckaerts C., Javoy-Agid F., Agid Y. Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography. Brain Res. 659:1994;1-9.
30. Leutz A., Schachner M. Epidermal growth factor (EGF) stimulates DNA-synthesis of astrocytes in primary cerebellar cultures. Cell Tissue Res. 220:1981;393-404.
31. 67. Neurology. 45:1995;127-134.
32. Lin L-F. H., Doherty D. H., Lile J. D., Bektesh S., Collins F. GNDF: A glial cell line derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
33. Loy R., Heyer D., DiStefano P. Sensitivity of substantia nigra neurons to epidermal groüwth factor. Soc. Neurosci. Abstr. 14:1988;302.
34. Luquin M. R., Obeso J. A., Herrero M. T., Laguna J., Martinez-Lage J. M. Parkinsonismo inducido por MPTP como modelo experimental de enfermidad de Parkinson: Similitudes y diferencias. Neurologia. 6:1991;287-294.
35. Knüsel B., Winslow J. W., Rosenthal A., Burton L. E., Sheid D. P., Nikolics K., Hefti F. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but by not neurotrophin 3. Proc. Natl. Acad. Sci. USA. 88:1991;961-965.
36. Knüsel B., Michel P. P., Schwaber J. S., Hefti F. Selective and nonselective stimulation of central cholinergic and dopaminergic developmentin vitro. J. Neurosci. 10:1990;558-570.
37. Mazzoni I. E., Kenigsberg R. L. Localization and characterization of epidermal growth factor receptors in the developing rat medial septal area in culture. Brain Res. 656:1994;115-126.
38. Mogi M., Harada M., Kondo T., Riederer P., Inagaki H., Minami M., Nagatsu T. Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients. Neurosci. Lett. 180:1994;147-150.
39. Morrison R. S., Kornblum H. I., Leslie F. M., Bradshaw R. A. Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor. Science. 238:1987;72-75.
40. Morrison R. S., Keating R. F., Moskal J. R. Basic fibroblast growth factor and epidermal growth factor exert differental trophic effects on CNS neurons. J. Neurosci. Res. 21:1988;71-79.
41. Nanney L. B., Wertner M., Stoscheck C., Birecree E., King L. E. Jr., Whetsell W. O. Epidermal growth factor-receptor (EGF-R) detected in normal human brain and in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 45:1986;339.
42. Nieto-Sampedro M. Astrocyte mitogen inhibitor related to epidermal growth factor receptor. Science. 240:1988;1784-1786.
43. Otto D., Unsicker K. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J. Neurosci. 10:1990;1912-1921.
44. ++. Brain Res. 599:1992;83-97.
45. Perry G., Richey P., Siedlak S. L., Galloway P., Kawai M., Cras P. Basic fibroblast growth factor binds to filamentous inclusions of neurodegenerative diseases. Brain Res. 579:1992;350-352.
46. Pezzoli G., Zecchinelli A., Ricciardi S., Burke R. E., Fahn S., Scarlato G., Carenzi A. Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian rats. Mov. Disord. 6:1991;281-287.
47. Plata-Salaman C. R. Epidermal growth factor and the nervous system. Peptides. 12:1991;653-663.
48. Rall L. B., Scott J., Bell G. I., Crawford R. J., Penschow J. D., Nial H. D., Coghlan J. P. Mouse prepro-epidermal growth factor synthesis by kidney and other tissues. Nature. 313:1985;228-231.
49. Reynolds B. A., Tetziaff W., Weiss S. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J. Neurosci. 12:1992;4565-4574.
50. Ruberg M., Hirsch E., Javoy-Agid F. Neurochemistry. Litvan I., Agid Y. Progressive Supranuclar Palsy - Clinical and Research Approaches. 1992;89-109 Oxford Univ. Press, New York.
51. Seroogy K. B., Numan S., Gall C. M., Lee D. C., Kornblum H. I. Expression of EGF receptor mRNA in rat nigrostriatal system. NeuroReport. 6:1994;105-108.
52. Styren S. D., Mufson E. J., Styren G. C., Civin W. H., Rogers J. Epidermal growth factor receptor expression in demented aged human brain. Brain Res. 512:1990;347-352.
53. Styren S. D., DeKosky S. T., Rogers J., Mufson E. J. Epidermal growth factor receptor expression in demented elderly: localization to vascular endothelial cells of brain, pituitary and skin. Brain Res. 615:1993;181-190.
54. Tooyama I., McGeer E. G., Kawamata T., Kimura H., McGeer P. L. Retention of basic fibroblast growth factor immunoreactivity in dopaminergic neurons of the substantia nigra during normal aging in humans contrasts with loss in Parkinson's disease. Brain Res. 656:1994;165-168.
55. Tooyama I., Walker D., Yamada T., Hanai K., Kimura H., McGeer E. G., McGeer P. L. High molecular weight basic fibroblast growth factor-like protein is localized to a subpopulation of mesencephalic dopaminergic neurons in the rat brain. Brain Res. 593:1992;274-280.
56. Tooyama I., Kawamata T., Walker D., Yamada T., Hanai K., Kimura H., Iwane M., Igarashi K., McGeer E. G., McGeer P. L. Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's disease. Neurology. 43:1993;372-376.
57. Tuszynski M. H., Gage F. H. Neurotrophic and neuronal loss. Katzman R., Bick K. L. Alzheimer's Disease. 1994;405-417 Raven, New York.
58. 125. Brain Res. 628:1993;72-76.
59. Villares J., Strada O., Faucheux B., Javoy-Agid F., Agid Y., Hirsch E. C. Loss of striatal high affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease. Neurosci. Lett. 182:1994;59-62.
60. Wang S-L., Shiverick K. T., Ogilvie S., Dunn W. A., Raizada M. K. Characterization of epidermal growth factor receptors in astrocytic glial and neuronal cells in primary culture. Endocrinology. 124:1989;240-247.
61. Werner M. H., Nanney L. B., Stoscheck C. M., King L. E. Localization of immunoreactive epidermal growth factor receptors in human nervous system. J. Histochem. Cytochem. 36:1988;81-86.